Literature DB >> 28093595

Mortality and Cause of Death in Patients with Pemphigus.

Khalaf Kridin1, Shira Zelber Sagi, Reuven Bergman.   

Abstract

All-cause and cause-specific mortality among patients with pemphigus compared with the general population is yet to be established. This study investigated overall mortality and cause-specific mortality in a large immunopathologically validated cohort of patients with pemphigus. Mortality of patients with pemphigus was compared with age- and gender-matched control subjects in the general population. All-cause and cause-specific standardized mortality ratios (SMRs) were estimated. The study cohort included 245 patients newly-diagnosed with pemphigus between January 1990 and June 2016, contributing 2,679.4 person-years of follow-up. Overall, 48 deaths were observed during a mean follow-up period of 10.9 ± 8.1 years, which was more than twice the number expected (SMR 2.4; 95% confidence interval (95% CI) 1.82-3.20). The SMRs for death due to infections (22.6; 95% CI 13.6-35.3), namely pneumonia (25.7; 95% CI 11.7-48.8) and septicaemia (8.6; 95% CI 1.7-25.0), and due to cardiovascular diseases (2.8; 95% CI 1.0-6.0) were significantly higher than expected. Overall mortality among patients with pemphigus is 2.4-times greater than for the general population, mainly due to infections.

Entities:  

Mesh:

Year:  2017        PMID: 28093595     DOI: 10.2340/00015555-2611

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  19 in total

1.  Association between schizophrenia and an autoimmune bullous skin disease-pemphigus: a population-based large-scale study.

Authors:  K Kridin; S Zelber-Sagi; D Comaneshter; A D Cohen
Journal:  Epidemiol Psychiatr Sci       Date:  2017-09-25       Impact factor: 6.892

Review 2.  The Immunogenetics of Autoimmune Blistering Diseases.

Authors:  Diana Kneiber; Eric H Kowalski; Kyle T Amber
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Clinical, Histopathologic, and Immunohistochemical Features of Patients with IgG/IgA Pemphigus.

Authors:  Yung-Tsu Cho; Ko-Ting Fu; Kai-Lung Chen; Yih-Leong Chang; Chia-Yu Chu
Journal:  Biomedicines       Date:  2022-05-22

4.  Coexistent Solid Malignancies in Pemphigus: A Population-Based Study.

Authors:  Khalaf Kridin; Shira Zelber-Sagi; Doron Comaneshter; Arnon D Cohen
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

5.  Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study.

Authors:  Khalaf Kridin; Christoph M Hammers; Ralf J Ludwig; Dana Tzur Bitan; Arnon D Cohen
Journal:  Acta Derm Venereol       Date:  2021-09-03       Impact factor: 3.875

6.  Inpatient Mortality Resulting from Dermatological Disorders at a Tertiary Care Center in Eastern India: A Record-based Observational Study.

Authors:  Satyendranath Chowdhury; Indrashis Podder; Abanti Saha; Debabrata Bandyopadhyay
Journal:  Indian J Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.494

7.  Increased Risk of Pemphigus among Patients with Psoriasis: A Large-scale Cohort Study.

Authors:  Khalaf Kridin; Ralf J Ludwig; Giovanni Damiani; Arnon D Cohen
Journal:  Acta Derm Venereol       Date:  2020-10-20       Impact factor: 3.875

8.  Autoimmune Thyroid Diseases and Thyroid Cancer in Pemphigus: A Big Data Analysis.

Authors:  Khalaf Kridin; Mogher Khamaisi; Doron Comaneshter; Erez Batat; Arnon D Cohen
Journal:  Front Med (Lausanne)       Date:  2018-05-30

Review 9.  Emerging treatment options for the management of pemphigus vulgaris.

Authors:  Khalaf Kridin
Journal:  Ther Clin Risk Manag       Date:  2018-04-27       Impact factor: 2.423

10.  Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin.

Authors:  A Razzaque Ahmed; Srinivas Kaveri
Journal:  Front Immunol       Date:  2018-07-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.